Abstract
P-glycoprotein, breast cancer resistance protein, and multidrug resistance proteins have physiological functions in placental tissue. Several antidepressants, antipsychotics, and anti-epileptic drugs have been found to be substrates of P-glycoprotein and other transporters. The extent that drugs pass through the placental barrier is likely influenced by drug transporters. The rational choice of psychoactive drugs to treat mental illness in women of child-bearing age should incorporate knowledge of both drug disposition as well as expected pharmacologic effects. This review summarizes the current data on drug transporters in the placental passage of medications, with a focus on medications used in clinical psychopharmacology.
Original language | English (US) |
---|---|
Pages (from-to) | 723-746 |
Number of pages | 24 |
Journal | Drug Metabolism Reviews |
Volume | 39 |
Issue number | 4 |
DOIs | |
State | Published - Oct 2007 |
Externally published | Yes |
Keywords
- Breast cancer resistance protein
- Drug transporters
- Multi-drug resistance protein
- P-glycoprotein
- Pregnancy
ASJC Scopus subject areas
- Pharmacology, Toxicology and Pharmaceutics(all)
- Pharmacology (medical)